ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • MSME Summit
  • Trending News
    • Viral News
    • Travel
    • People
    • Entertainment
    • Sports
  • More ...
    • VIDEOS
    • PHOTOS
BREAKING NEWS
  • New Virus in China 2022: Langya ALERT! No vaccine, no treatment!
  • Policybazaar system vulnerabilities exposed customers' personal details, says this report
  • Government removes cap on airfares with effect from 31 August
  • Samsung Galaxy Z Fold 4, Galaxy Z Flip 4, Watch 5 series, Buds 2 Pro revealed - price, India availability, specs and more
  • Maruti Suzuki Alto K10 2022 bookings open; Check token amount and how to book online
Read in App
Business News » Companies News

Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr

For the 2018-19 fiscal, the company's net profit was Rs 1,492.44 crore as against Rs 1,416.57 crore in 2017-18. Total revenue from operations for the last fiscal stood at Rs 16,362.41 crore. It was Rs 15,219.25 crore in the preceding financial year.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr
In a separate filing, Cipla said its board has approved raising funds up to Rs 6,000 crore. Image source: Reuters

Drug major Cipla Wednesday reported over two-fold jump in consolidated net profit to Rs 357.68 crore for the fourth quarter ended March 31, mainly on account of robust sales across markets. The company has also decided to raise funds of up to Rs 6,000 crore.

It had posted a net profit of Rs 153.25 crore for the corresponding period previous fiscal, Cipla said in a BSE filing. Consolidated total revenue from operations stood at Rs 4,403.98 crore for the quarter under consideration. It was Rs 3,697.97 crore for the same period a year ago.

For the 2018-19 fiscal, the company's net profit was Rs 1,492.44 crore as against Rs 1,416.57 crore in 2017-18. Total revenue from operations for the last fiscal stood at Rs 16,362.41 crore. It was Rs 15,219.25 crore in the preceding financial year.

In a separate filing, Cipla said its board has approved raising funds up to Rs 6,000 crore.

The board has approved "raising funds up to Rs 3,000 crore by issue of equity shares or American depository receipts or global depository receipts or foreign currency convertible bonds or other securities / financial instruments convertible into equity shares, whether denominated in Indian Rupee and/or foreign currency(ies), though a public issue or a private placement...," Cipla said.

The board has also approved raising funds up to Rs 3,000 crore by issue of non-convertible debentures or bonds, whether denominated in Indian Rupee and/or foreign currency(ies), though a public issue or a private placement, it added.

The company is seeking approval of shareholders to the enabling resolutions at the ensuing annual general meeting.
"FY19 ended on a strong note for Cipla. While our home markets of India and South Africa continued to lead the way, our US business established robust base growth from differentiated direct-to-market launches," its MD and Global CEO Umang Vohra said.

The company's planned build-up of respiratory pipeline in the US remains on track. Challenges in the tender businesses and certain volatile markets played out as guided previously, he added.

"Most importantly, in FY19, we made important strides in broadening our offerings to patients around the world through health campaigns, innovative products, strategic acquisitions and digital healthcare solutions. From a sustainable growth and direction perspective, we are well-poised for FY20," Vohra said.

The company's board has recommended a final dividend of Rs 3 per equity share for the financial year ended March 31, 2019, Cipla said.

Shares of Cipla were trading at Rs 572.80 per scrip on the BSE, up 2.51 per cent from its previous close. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
CiplaPharma
Written By: PTI
Updated: Wed, May 22, 2019
03:50 pm
New Delhi, PTI
RELATED NEWS
Cipla business plan: Drug major betting big on digitisation and emerging segments Cipla business plan: Drug major betting big on digitisation and emerging segments
Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this
Q1 Results FY2023: NTPC, Cipla, Emami, Exide Industries, EIH announce June quarter results - highlights Q1 Results FY2023: NTPC, Cipla, Emami, Exide Industries, EIH announce June quarter results - highlights
Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22% Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%
Cipla Share Price: After company reports healthy March quarter numbers, brokerages turn bullish on stock; recommend buy Cipla Share Price: After company reports healthy March quarter numbers, brokerages turn bullish on stock; recommend buy

LATEST NEWS

Raju Srivastav suffers heart attack at gym, admitted to AIIMS in Delhi

Raksha Bandhan Bank Holiday: Will banks be functional in your city on Rakhi? Check state-wise list here

Government removes cap on airfares with effect from 31 August

Anil Singhvi's strategy on Aug 10: Support zone on Nifty is 17400-17475, Bank Nifty is 37975-38050

Samsung Galaxy Z Fold 4, Galaxy Z Flip 4, Watch 5 series, Buds 2 Pro launched- price, India availability, specs and more

ITC Hotels unveils ITC Narmada - 12th property in Gujarat

Twitter outage: Micro-blogging platform hit by technical snag; company says 'fixed it'

Asian shares slip ahead of crucial US inflation data

Bihar New Govt Portfolios: Who will get what in Nitish-Tejashwi cabinet? JDU, RJD, Congress, HAM - List

Raksha Bandhan 2022 correct date, best time; Rakhi Shubh Muhurat in India - Know inauspicious Bhadra, what to avoid as per Hindu calendar

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2022. India Dot Com Private Limited. All Rights Reserved.
LIVE TV